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Abstract: We report here that earthworm can be used as an in vivo system to prescreen antimitotic compounds. The known antimitotic
compound colchicine and the aqueous extract of Acorus calamus L. rhizome were used to examine this system. The antimitotic
activity of colchicine and the rhizome extract was confirmed by methods with Allium cepa root tip, earthworm regeneration, and
MTT (3-(4,5-dimethyl thiazolyl-2-yl)-2,5-diphenyltetrazolium bromide). An earthworm regeneration assay examined the regeneration
ability of tissues from amputated regions of the earthworm. All 3 assays showed that cell division is inhibited with colchicine and the
aqueous extract of A. calamus rhizome. Histology studies with amputated earthworms confirmed that the development of the blastema
was observed only in control worms. Immunohistochemistry analysis with proliferation cell nuclear antigen and phospho serine 10
histone H3 antibodies showed that amputated worms treated with colchicine or the aqueous extract of A. calamus did not have active
cell division. MTT assay with the MCF-7 cell line (human breast carcinoma) further confirmed that the aqueous extract of rhizome
affected cell proliferation. Our results suggest that the earthworm could be used to prescreen the antimitotic potential of plant extracts
or other unknown compounds. It is simple, reproducible, and cost-efficient compared to animal cell line-based methods.
Key words: Antimitotic, Acorus calamus, colchicine, earthworm regeneration assay, Eudrilus eugeniae, immunohistochemistry

1. Introduction
Antimitotic compounds identified from plants have
shown great success in the treatment of cancer (Gascoigne
et al., 2009; Weaver, 2014). Research on the screening of
anticancerous compounds has been increasing due to the
availability of millions of natural resources (Fouché et
al., 2008; Fadeyi et al., 2013). To evaluate the antimitotic
potential of an unknown compound, plant-based methods
using onion root tips, potato tubers, or green gram seeds
have been in practice (Eigsti, 1938; Coker et al., 2003;
Murthy et al., 2011). However, in vivo or animal cell
culture-based methods are now being used to confirm the
antimitotic, cytotoxic, or anticancerous activity of these
compounds (Sreejaya et al., 2013). A handful of alternative
animal-based in vivo methods (other than mice) have
been reported using sea urchin embryos, brine shrimp, or
embryos of zebra fish (Ved et al., 2010; Semenova et al.,
2011; Li et al., 2012). These methods may be useful in terms
of high-throughput analysis and low expense compared to
methods that require an animal cell culture facility.
Here we introduce the earthworm, Eudrilus eugeniae,
as an alternative inexpensive and novel in vivo system to

identify compounds with antimitotic potential. This species
possesses the ability to regenerate lost segments if they
retain the clitellum region, a thick cylindrical collar-like
structure present in the anterior part of the body (Samuel
et al., 2012). Amputated earthworms with clitellum regions
were used for the experiments, as the regeneration of tissues
must go through rapid mitosis for blastema development.
Amputated earthworms were tested with a commercially
available antimitotic compound, colchicine, or with the
extract from the rhizome of A. calamus L. (Acoraceae),
which has been reported to have cytotoxic or antitumor
properties (Bhattacharyya et al., 2008; Rajkumar et al.,
2009; Imam et al., 2013).
It has been reported that the US National Cancer
Institute has been performing prescreening through a
3-cell panel having SF-268 CNS, NCI-H460 lung, and
MCF-7 breast cancer cells (Pan et al., 2010). The purpose
of this study is to develop a simple and reliable animalbased in vivo system to prescreen hydrophilic antimitotic
compounds, which could be used worldwide, even with
limited facilities. This new system would help to accelerate
the prescreening of new drug molecules. We have used
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commercially available colchicine and the aqueous extract
of rhizomes of A. calamus to validate this new model
system. To confirm the antimitotic activity, both in vitro
and in vivo experiments were performed. We propose that
earthworms could be used as a simple, less expensive, and
novel system to prescreen antimitotic compounds.
2. Materials and methods
2.1. Plant materials
The rhizomes of A. calamus L. and bulbs of Allium cepa
L. were purchased from herbal stores or local markets
and authenticated by Dr V Ganesan (taxonomist) in the
Department of Botany at ANJAC College, Sivakasi, Tamil
Nadu, India.
2.2. Chemicals
Hematoxylin stain and antibodies were purchased from
Sigma-Aldrich, India. All other analytical grade chemicals
and solvents were purchased from HiMedia or Merck Ltd.,
India.
2.3. Preparation of rhizome extract and colchicine
Rhizomes of A. calamus were washed thoroughly, airdried, and powdered. Each 1 g of the powdered sample
was extracted with 10 mL of sterile distilled water and
kept overnight in a shaker at room temperature . Waterextracted samples were filtered with Whatman No. 1 filter
paper, followed by a 0.2-µm filter. Water was evaporated
with a water bath and the resultant residue was weighed
and dissolved in sterile distilled water and stored in a
freezer. When required, 100 mg/mL stock was prepared
and diluted 100 times before use (1 mg/mL). Colchicine
(Cat. No. RM342, HiMedia, India) was dissolved in sterile
distilled water to prepare 10 mg/mL stock solution and
diluted with water to prepare 100 µg/mL working solution.
2.4. Allium cepa root tip assay
The A. cepa root tip assay was performed as described
earlier (Kundu et al., 2016). Briefly, Allium cepa bulbs were
kept in distilled water in 100-mL beakers under laboratory
conditions to initiate root germination. Onion bulbs with
newly germinated roots were incubated with distilled
water, colchicine, or water extract of A. calamus rhizome
for 16 h. Onion bulbs treated with distilled water were
used as the control while colchicine served as the positive
control. Following the incubation period, root tips were
fixed with ethanol and acetic acid (3:1) for 10 min and
washed with sterile distilled water. Root tips were treated
with 1 N hydrochloric acid and kept for 10 min in a 60
°C water bath. Root tips were washed with sterile distilled
water, stained with 0.5% safranin stain (W/V), and
observed under a light microscope (40×). Chromosome
morphology and stages were observed to calculate mitotic
index. The mitotic index was calculated using the formula
given below.
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Mitotic index percentage (%MI) =
Total number of cells in mitosis
× 100
Total number of cells counted

2.5. Culture and maintenance of earthworm
Adult earthworms E. eugeniae were collected from the
Agricultural Support Centre (Plant Clinic Centre), Tamil
Nadu Agricultural University, Tirunelveli. E. eugeniae was
maintained in a plastic tub containing soil, cow dung, and
leaf litter in appropriate moisture conditions.
2.6. Toxicity studies
For toxicity studies, colchicine was prepared as 10 µg/mL,
100 µg/mL, and 1 mg/mL using sterile distilled water from
the stock of 10 mg/mL. For rhizome extract, 10 mg/mL or
1 mg/mL was prepared from the water bath’s evaporated
residue as described in Section 2.3. These samples were
tested on amputated earthworms (as described in Section
2.7) or onion roots, and their phenotype was monitored
for 8 days.
2.7. Earthworm regeneration assay
In this study, the earthworm regeneration assay is used to
check the antimitotic potential of a known or unknown
compound. Healthy adult earthworms of similar sizes,
ranging from 1.0 to 1.5 g in body weight, were carefully
selected for the experiments. Earthworms were cut with a
sterile scalpel blade on the 30th segment from the mouth
and the posterior segments were amputated, while the
anterior parts of the body including the clitellum region
were kept in separate beds and monitored every 24 h, with
special attention paid to the amputation region for wound
healing and/or formation and growth of the blastema.
Earthworms were injected between the clitellum and
the amputation region with 10 µL of distilled water or
aqueous drug solution. Injections were performed at 24-h
intervals for 3 or 7 consecutive days. Five worms were used
for each treatment and all experiments were performed at
least 3 times.
2.8. Stereo zoom microscope analysis
Amputated regions of earthworm were observed from the
first day to the seventh day to record the morphological
changes that occurred during blastema development.
Worms were anesthetized with 10% ethanol before
observation under a Nikon SMZ800 Stereo zoom
microscope (Kalidas et al., 2015).
2.9. Histology
The structural changes of the amputated regions of
the earthworms at the cellular level were studied using
histology as described earlier (Kalidas et al., 2015). After 3
days of treatment, earthworm tissues near the amputated
regions were used for histological analysis. The earthworm
tissues were fixed with 10% formaldehyde for 24 h and
dehydrated using gradient isopropanol treatment (70%,
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80%, 90%, and 100%, each for 1 h). Tissue clearing was
subsequently achieved by treatment with xylene for 45 min,
followed by wax impregnation. The 6-µm thin sections
were made from the middle part of the block by microtome
(Besto). The wax in the tissue sections was removed by
washing with xylene and isopropanol. Later, tissues were
stained with hematoxylin and eosin. The stained slides were
mounted with DPX and documented under an Olympus
BX53 microscope. Presence or absence of antimitotic activity
was observed by noting healed wounds or development of
the blastema respectively in the amputated regions.
2.10. Immunohistochemistry
To identify whether mitotic cell division was inhibited
or not, earthworms injected with water, colchicine,
or aqueous extract of rhizomes were subjected to
immunohistochemistry (as described by Subramanian
et al., 2017) with primary monoclonal antibody of antiPCNA (Cat. No. WH0005111M2, Sigma-Aldrich, India)
or anti-Phospho H3 [pSer10] (Cat. No. H0412, SigmaAldrich, India). Paraffin-embedded earthworm tissues
were sectioned to 6 µm in thickness and dewaxed with
xylene. Rehydrated sections were incubated for 30 min
with freshly prepared 10% H2O2 and 10% methanol in
phosphate buffered saline (1X PBS) to inhibit endogenous
peroxidase activity. These sections were later treated with
0.1% trypsin in 0.1% CaCl2 at 37 °C for 10 min. To avoid
nonspecific binding or staining, sections were treated
with 2% bovine serum albumin (BSA) in 1X PBS for 1 h
at room temperature. The primary monoclonal antibody
of anti-PCNA or anti-phospho H3 [pSer10] was diluted
at a concentration of 1:200 in 2% BSA solution (1X PBS)
and incubated with respective sections overnight at 4 °C.
Sections were washed with PBS buffer and incubated
with secondary antibody (goat antimouse IgG conjugated
with horseradish peroxidase) at a dilution of 1:2000 in 1X
PBST (Tween 20). Peroxidase activity was identified with
a DAB Kit (GeNei), and the sections were counterstained
with Ehrlich’s hematoxylin. The slides were mounted with
DPX to document observations under an Olympus BX53
microscope. Brown spots resulting from agglutination
reaction were counted for all slides prepared from each
respective group of worms. Positive cells were counted from
10 different random images (40×) of each treatment and
divided by the total number of cells.
2.11. Statistical analysis
Statistical analysis was performed (mean, standard
deviation, and standard error) with Tukey’s multiple
comparisons test in the software tool GraphPad Prism 6.0.
P < 0.05 was considered statistically significant.
2.12. MTT assay
An assay with the MCF-7 cell line (human breast carcinoma)
was performed at the JSS College of Pharmacy, Ooty, Tamil

Nadu, as described earlier (Denizot and Lang, 1986). The
monolayer cell culture was trypsinized and the cell count
was adjusted to 1.0 × 105 cells/mL using DMEM medium.
To each well of a 96-well microtiter plate, 100 µL of the
diluted cell suspension (approximately 10,000 cells/well)
was added. After 24 h, the monolayer was washed once with
medium and 100 µL of different test sample concentrations
prepared in maintenance media were added per well. The
plates were then incubated at 37 °C for 48 h in a 5% CO2
atmosphere and microscopic examination was carried out.
After 48 h, the sample solutions in the wells were discarded
and 20 µL of MTT (2 mg/mL) in MEM-PR (MEM without
phenol red) was added to each well. The absorbance was
measured using a microplate reader at a wavelength of 540
nm.
The percentage of growth inhibition was calculated
using the following formula and concentrations of test
samples needed to inhibit cell growth by 50% values (IC50)
were generated from the dose–response curves for each
cell line.
% of cytotoxicity =
Mean OD of individual test group
× 100
Mean OD of control group
		
3. Results
3.1. Toxicity studies of colchicine and aqueous extract of
Acorus calamus rhizome
A concentration of colchicine of 1 mg/mL was lethal to
earthworms and caused stunted or deformed growth in
A. cepa root tips. We used 100 µg/mL as it did not affect
the growth or phenotype of A. cepa roots or earthworms
(Levan, 1938; Kundu et al., 2016). Aqueous extract of A.
calamus rhizome (10 µL) was tested at 2 concentrations, 1
mg/mL or 10 mg/mL; neither was toxic to worms (data not
shown). Toxicity was assessed by the presence or absence of
deformation of worm tissue in any body part or autotomy.
Since neither concentration affected the worm phenotype,
1 mg/mL was chosen for all remaining experiments.
3.2. Allium cepa root tip assay to test antimitotic activity
Preliminary cytotoxicity or antimitotic studies began
with the A. cepa root tip assay, and further confirmation
was done with in vivo or in vitro assays using mouse,
human, or cancer cell lines. A. cepa root tip assay was
performed to confirm that colchicine and the aqueous
extract of rhizomes of A. calamus exhibited antimitotic
properties. Root tips of A. cepa treated with water showed
all 4 stages of mitotic cell division (Figure 1A). Root tips
treated with colchicine showed more metaphases than
other phases of mitosis (Figure 1B). Interestingly, root tips
that were treated with the aqueous extract of rhizomes
showed only a few metaphases or anaphases but showed
more prophases (Figure 1C). Panels in Figure 1 (1D–1F)
represent the type of mitotic phases observed in water,
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colchicine, and aqueous extract of rhizomes, respectively.
Colchicine- and rhizome extract-treated root tips showed
fewer dividing cells. To get quantitative data, the mitotic
index was calculated following all 3 treatments. Aqueous
extract of A. calamus rhizomes and colchicine significantly
decreased the mitotic index of A. cepa cells compared
to control (water-treated) samples (Figure 1G). This
strongly suggests that the aqueous extract of rhizomes has
antimitotic compounds.
3.3. Validation of earthworm regeneration assay
The earthworm E. eugeniae is a segmented worm with a
clitellum that divides the worm into anterior and posterior
regions (Figure 2A). Regeneration of the blastema from
amputated regions has been reported in this species
(Samuel et al., 2012). Regeneration of the blastema from
amputated regions, which requires rapid mitotic cell
division, is generally observed 3 days after amputation.
Regeneration ability of amputated regions was used to
validate the antimitotic potential of the compounds.
Samples of sterile distilled water (control), colchicine, or
aqueous extract of A. calamus were injected once every 24
h for a period of 7 days. Wounds in the amputated regions
of all worms were healed within 24 h. The regeneration
of the blastema was observed after 3, 5, or 7 days in all
control worms (Figures 2B–2D). The development of
the blastema was inhibited by colchicine until 3, 5, or 7
days after amputation (Figures 2E–2G). This indicates
that colchicine inhibited mitosis in the amputated region;
hence, the blastema was not observed. Development of
the blastema was observed in these worms when injection
of colchicine was stopped (data not shown). Similarly,
regeneration of blastema was not observed in worms that
were injected with extract of A. calamus rhizomes 3, 5, or 7
days after amputation (Figures 2H–2J). This demonstrates
that extracts of A. calamus possess compounds with
antimitotic activity. Hence, this assay could be used to
validate unknown antimitotic compounds.
3.4. Confirmation of antimitotic activity by histology
and immunohistochemistry
Inhibition or development of the blastema in the amputated
regions was verified by stereo zoom microscope. Panels
of Figure 3 (3A–3C) show that blastemas were observed
in water-treated samples (Figure 3A) and inhibited in
colchicine- or rhizome extract-treated worms (Figures
3B and 3C). In order to study the inhibition of blastema
formation further, blastemas (with adjacent segments)
were processed for histology. Earthworms that were
injected with water, aqueous extract of rhizome, or
colchicine were processed for histological analysis after
3 days of treatment. Staining with hematoxylin and eosin
and observation under a light microscope showed the
presence of the outermost epithelial cell layer (ECL), the
middle circular muscle layer (CML), and the innermost
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longitudinal cell layer (LCL) in the skin region. These 3
layers were very clear in control worms compared to the
other worms (Figure 3D); specifically, the ECL and LCL
layers are thicker in control worms and thinner in the
treated worms. Among the 3 skin layers, the innermost
LCL of the skin grew and extended as blastema only in
the worms that were injected with sterile distilled water
(Figure 3D). This innermost layer must undergo active
mitotic cell division for blastema development (Santos et
al., 2002). Earthworms that were injected with colchicine
or aqueous extract of A. calamus did not show any further
growth of the innermost layer development into blastema
(Figures 3E and 3F). However, wound healing at the site of
the amputation was observed. Histology studies confirmed
that there was no development of blastema in the worms
injected with either colchicine or rhizome extract, which
suggests that the aqueous extract of rhizome possesses
antimitotic activity similar to that of colchicine.
To demonstrate inhibition of cell division, tissues in the
amputated region were taken for immunohistochemical
analysis 3 days after the injection of all 3 samples. PCNA is
a cell cycle marker protein, expressed only in S (synthesis)phase cells and abundant in actively dividing cells (Foley
et al., 1991). Phospho serine 10 histone H3 protein is
expressed only in M (mitosis)-phase cells; hence, more of it
is found in tissues where mitosis is inhibited (Subramanian
et al., 2017). Antibodies of these 2 mitosis-specific proteins
were used to find the mitotic cells in the blastema and
nearby segments of the regenerating earthworms. Positive
cells were calculated as described in Section 2. Figure
4A shows that the tissues of the control worms injected
with sterile distilled water have more PCNA-expressing
cells, which indicates active cell division. More PCNA is
available in the synthesis phase of cells. The comparison
of the status of PCNA-bound agglutinations in the groups
of worms injected with either colchicine or extract of A.
calamus clearly shows that agglutinations with PCNA were
significantly reduced (Figures 4B and 4C). In contrast,
expression of phospho serine 10 histone H3 was lower in
control worms (Figure 4D). Interestingly, expression of this
protein was enriched significantly in the worms injected
with colchicine or extract of A. calamus (Figures 4E and
4F, respectively). Statistical analysis showed significant
differences in expression of PCNA protein between the
control worms and those treated with colchicine or the
rhizome extract when counting PCNA antibody-bound
positive cells against the total number of cells (Figure 4G).
This suggests that the number of cells in the synthesis
phase of mitosis is significantly greater in control worms
compared to worms injected with colchicine or the
rhizome extract. The data clearly confirm that the cell
division potential has been reduced significantly by the
injection of colchicine or extract of A. calamus. Statistical
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Figure 1. Inhibition of cell division in Allium cepa root tips by colchicine and water extract of Acorus calamus. All root tips were incubated
with respective samples for 16 h before the processing. A) Different stages of mitosis of roots treated with distilled water, observed with a
40× objective lens; B) the arrest of cell division predominantly in metaphase by colchicine (100 µg/mL); C) more prophases compared to
the stages of metaphase and anaphase in samples treated with Acorus calamus (1 mg/mL); D) magnified images of all 4 phases of mitosis
(prophase, metaphase, anaphase, and telophase) in water-treated samples; E) the magnified images of 6 metaphases and 1 anaphase in
colchicine-treated samples; F) the magnified images of metaphase, anaphase, and prophase. The graph (G) shows the % of cells observed
in different phases of mitotic cell division with mean ± SEM bar and P-value (***: P < 0.05). Marked circles indicate the different phases
of cell division.

data with phospho serine 10 histone H3 antibody shows
that its expression was lower in control worms (Figure
4H) compared to that of worms treated with colchicine
or the rhizome extract, which indicates that in control
worms many cells in and around the amputated region
passed the mitosis phase and moved to the next phase
of the cell cycle. This suggests that many cells in worms
treated with colchicine or the rhizome extract are in the
mitotic phase, as the cell division is inhibited. It appears
that colchicine arrested the cell division at the mitotic
stage, possibly by inhibiting the polymerization of
microtubules, as has been reported earlier (Jordan et al.,
2004). Therefore, if colchicine arrests cell division, the
number of cells that would go through the synthesis phase
would be lower. This is clearly reflected by the number of
PCNA antibody-bound positive cells in worms treated
with colchicine. It is also in agreement with the number

of phospho serine 10 histone H3 antibody-bound positive
cells in the worms treated with colchicine; worms injected
with colchicine have a high number of cells in the mitotic
phase. Immunohistochemistry data suggest that colchicine
inhibited the cell division in the amputated region better
than the rhizome extract of A. calamus. The data clearly
show that the extract of A. calamus has an antimitotic
compound that can arrest the cell cycle at the mitotic stage.
Although there was no blastema development due to the
inhibition of cell division, the wounds of these worms
were healed at the amputation sites within 24 h like those
of the control worms. Our data suggest that earthworm
regeneration in amputated regions could be exploited to
validate antimitotic compounds.
3.5. Validation by MTT assay
To test the authenticity of the earthworm regeneration
assay, MTT assay using the MCF-7 breast carcinoma cell
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Figure 2. Inhibition of blastema development in Eudrilus eugeniae by colchicine and aqueous extract of Acorus calamus. A) The adult
earthworm, E. eugeniae, is marked to show anterior (ar), clitellum (cl), and posterior (pr) regions. The control worms were injected with
distilled water every 24 h for a period of 7 days, and the development of the blastema was observed after day 3 (B), day 5 (C), or day 7
(D). Colchicine was injected similarly for 7 consecutive days and the development of blastema was not observed after day 3 (E), day 5
(F). or day 7 (G). Aqueous extract of A. calamus rhizomes was injected every 24 h for a period of 7 days and the development of blastema
was not observed after day 3 (H), day 5 (I), or day 7 (J). rb - regenerating blastema, wh - wound healing.
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Figure 3. Microscopy analysis of blastema development. Worms treated with water showed development of blastema 3 days after
amputation (A), whereas wound healing alone was observed in worms treated with colchicine (B) or aqueous extract of A. calamus
(C). Healed wounds are indicated by arrows. Histological studies show the regenerating budding tissue in water-treated worms (D),
healed wounds alone in colchicine-treated worms (E), or aqueous extract of A. calamus (F). All tissues (D, E, and F) were stained
with hematoxylin and eosin and were photographed with 4× magnification using a light microscope. The arrows in panels D, E,
and F indicate the borders of the lesion. rb - regenerating blastema, wh - wound healing, ECL - epithelial cell layer, CML - circular
muscle layer, LCL - longitudinal cell layer. Scale bar equals 50 µm.

line was performed, and the results are shown in the Table.
The MTT assay can be used to measure cytotoxicity or
cytostatic activity. Colchicine inhibited cell proliferation
better than the aqueous extract of rhizomes. However, both
colchicine and rhizome extract inhibited cell proliferation
and it was dependent on the concentration used. The
half-maximal inhibition concentration (IC50) values of
colchicine and rhizome extract were 3.17 µg/mL and 76.11
µg/mL, respectively. Cells appeared healthy in the control
treatment (Figure 5A). Inhibition of cell proliferation of
MCF-7 breast cancer cells by colchicine (Figure 5B) and
the rhizome extract (Figure 5C) was observed, as their cell
morphology was different in size and shape compared to
how cells appeared in the control.
4. Discussion
Compounds obtained from plants or other natural
resources may provide drugs or leads for potential
ingredients for cancer treatment (Khazir et al., 2014).

Antimitotic compounds isolated from plants are currently
being used as chemotherapeutic agents to control cancer
disease. For example, microtubule-stabilizing compounds
like taxol and its derivatives have been on the market to
treat ovarian cancer, breast cancer, and non-small-cell lung
cancer for more than 35 years. Chemotherapy is done with
a mixture of compounds that inhibit cell division (Mukhtar
et al., 2014). Development of resistance to antimitotic
drugs is one of the issues of chemotherapy (Vuuren et al.,
2015). Another problem is that compounds like taxanes
and vinca alkaloids are hydrophobic in nature and are
transported outside the cell by efflux pumps (Cella et al.,
2003; Baldo et al., 2013). Therefore, to identify hydrophilic
antimitotic compounds, the aqueous extract of A. calamus
rhizomes was tested. All of our results suggest that the
rhizome of this plant contains a hydrophilic antimitotic
compound. However, more compounds should be
screened worldwide to discover new active ingredients to
treat cancer. Cancer cell lines or in vivo animal models in
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Figure 4. Immunohistochemistry study with mitosis-specific antibodies: Panels A, B, and C show the analysis of worms treated with
water, colchicine, or aqueous extract of rhizomes, respectively, and tested with PCNA antibody. A) High number of PCNA positive cells
is shown with 40× lens. Lower number of PCNA-positive cells is shown in panels B and C. Panels D, E, and F show the analysis of worms
treated with water, colchicine, or aqueous extract of rhizomes respectively, treated with phospho serine 10 histone H3 antibody. D) A
low number of histone H3-positive cells is shown with 40× magnification. A high number of H3-positive cells is shown in panels E and
F. Quantitative analysis of positive cells with PCNA (G) and histone H3 (H) cells are shown with mean ± SEM bar and P value (**:P <
0.05). Scale bar equals 50 µm.

use to examine cytotoxic, antimitotic, or anticancerous
properties are expensive (Tannous et al., 2013). We need a
simple system to screen more compounds anywhere in the
world, even with limited facilities. We have demonstrated
such a system here with earthworms to prescreen unknown
compounds for their antimitotic potential. This system
was validated with the commercially available known
antimitotic compound colchicine and aqueous extracts of
rhizomes of A. calamus.
Our results with the onion root tip assay agree with
those of a previous report where the mitotic index was
reduced with the aqueous extract of the A. calamus rhizome
(Rajkumar et al., 2009). However, the authors referred
to it as cytotoxic rather than antimitotic. Cytotoxicityspecific features, such as a micronucleus or chromosomal
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Table. IC50 values of colchicine and water extract of rhizomes of
A. calamus in MCF-7 cell line.
Sample

IC50 (µg/mL)

Colchicine

3.17

A. calamus extract

76.11

aberrations in root tip cells, were not observed with the
colchicine or rhizome extract at the concentrations we
used. Colchicine has been shown to have cytotoxicity
and antimitotic potential at concentrations of 0.4 mg/mL
and 0.1 mg/mL, respectively (Kundu et al., 2016). Hence,
the same compound at higher concentrations might be
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Figure 5. Inhibition of cell proliferation by colchicine and rhizome extract: MTT assay with the MCF-7 breast cancer cell line was performed after 48 h of incubation of samples. The cells were cultured with various concentrations of colchicine and rhizome extract. Panels
A, B, and C show the cells treated with sterile distilled water, colchicine, and aqueous extract of rhizomes, respectively. Concentrations
at which colchicine and rhizome extract induced 50% of growth inhibition (IC50) are shown here.

cytotoxic. The concentration of colchicine used in our
experiments was 0.1 mg/mL. It has not yet been reported
that the aqueous extract of A. calamus has antimitotic
properties. Our results suggest that aqueous extract of
A. calamus rhizome inhibits mitosis in onion root tips,
as the mitotic index was reduced and chromosomal
abnormalities were not found. The onion root tip assay
has been used worldwide for many years to prescreen
antimitotic compounds and to study toxicity as well.
Likewise, earthworms can be used as a simple in vivo
animal-based system to prescreen antimitotic compounds.
It is expected that active mitotic cell division in
amputated regions of the earthworm is required for
blastema development after wounds heal. Hence, the
regeneration potential of amputated earthworms can
be exploited to examine the potential of antimitotic
compounds. Earthworms can also be used to study the
genes involved in the regeneration of tissues. The role of
the TCTP protein in the regeneration of tissues has been
shown recently with amputated earthworms and cell
division-specific antibodies (Subramanian et al., 2017).
In our experiments, all amputated earthworm wounds
were healed within 24 h. Regeneration of the blastema
was visible 3 days after amputation in control worms.
However, regeneration of the blastema was not observed,
even after 7 days, in worms injected with colchicine and
aqueous extract of rhizomes. This finding was confirmed
by stereo zoom light microscope. Histochemical studies of
earthworms with amputations showed that the innermost
LCL of skin layers extended to the blastema only in control
worms. None of the skin layer was extended further for
blastema development in worms treated with colchicine
or aqueous extract of rhizomes, possibly due to their
antimitotic properties. To confirm that the blastema
development was affected by inhibition of cell division, an
immunohistochemistry analysis with cell division-specific

antibodies was performed. Antibodies of PCNA, found
more in the synthesis phase of dividing cells, showed
that worms injected with colchicine and aqueous extract
of rhizomes have less agglutination compared to control
worms. In contrast, antibodies of phospho serine 10 histone
H3, found more in the mitotic phase of cells, showed that
worms injected with colchicine and aqueous extract of
rhizomes have more agglutination compared to control
worms. This result indicates that worms injected with
colchicine or rhizome extract did not have more cells with
G1 phase or G2 phase when compared with control worms.
This was further validated by MTT assay with the MCF-7
breast cancer cell line. Hence, the MTT assay can also be
used to examine cytostatic cells; it would help to identify
whether colchicine or compounds in the rhizome extract
influence cell proliferation. Both colchicine and rhizome
extract affected cell proliferation of breast cancer cells.
There is a difference between the IC50 values of colchicine
and rhizome extract, which shows the difference between
testing the purified antimitotic compound and the crude
extract. Data from the MTT assay corresponded with
earthworm regeneration assay and immunohistochemical
assay results. Methanolic extract of powdered A. calamus
plant has been shown to have an IC50 value of 52.07 µg/
mL (Sreejaya and Santhy, 2013). Methanolic extract of
rhizome powder showed better IC50 values compared to
aqueous extract in an XTT assay using MDA-MB-435
and Hep3B cell lines (Rajkumar et al., 2009). However,
our IC50 values were higher with the breast cancer cell
line (73 µg/mL), as the sample had been extracted with
water rather than methanol. Methanol, an organic solvent,
may extract the compound β-asarone from A. calamus
rhizomes. It has been reported to affect cell division in
cancer cell lines (Wu et al., 2015). β-Asarone is a volatile,
lipophilic oil extracted by organic solvents (Shailajan et al.,
2015). This suggests that our aqueous extract of rhizome
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possesses antimitotic compounds other than β-asarone.
It could be one of the reasons for minor variations in the
IC50 values when compared to previously reported data.
Earthworms are sensitive to organic solvents, so it is more
suitable to examine water-soluble compounds. This would
help to identify more hydrophilic compounds rather than
hydrophobic compounds.
Hence, as the results from the aqueous extract of A.
calamus with A. cepa root tip assay, immunohistochemical
studies, and MTT assay correspond well with data
obtained from colchicine, we conclude that the rhizome
possesses an antimitotic compound. Our results indicate
that the earthworm regeneration assay could be used as
an alternative, novel, economical system for screening
compounds with antimitotic potential. Experiments with
cancer cell lines or the mouse in vivo model system require
expensive facility infrastructures (Ryan, 1994), which may

not be affordable for all laboratories around the world.
Immunohistochemistry and MTT assays are expensive;
we performed them only to validate the earthwormbased system. Selected samples after prescreening with
earthworms may require further confirmation with in
vitro or in vivo methods. In addition, obtaining an ethical
clearance certificate may not be necessary for using
earthworms in experiments, or may be relatively simple
(Festing et al., 2007; Doke and Dhawale, 2015). This
novel system can be adopted very easily by any researcher
wherever earthworms can be grown.
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